ADA2

ADA2 (PF3D7_1014600) is a transcriptional coactivator in Plasmodium falciparum that functions as a partner of the histone acetyltransferase PfGCN5 within GCN5/ADA2-containing complexes implicated in chromatin regulation during the erythrocytic stages (PMID:15075257, PMID:15246536, PMID:31728527). Physical association with PfGCN5 was established through yeast two-hybrid and in vitro binding assays and confirmed in vivo, where anti-ADA2 antibodies co-precipitate GCN5-like HAT activity from parasite lysate (PMID:15075257, PMID:15246536). Quantitative interaction proteomics places ADA2 as a component of at least one of two distinct GCN5/ADA2 complexes that show extensive interconnection with other epigenetic subcomplexes (PMID:31728527). ADA2 carries an ADA2-like domain near the C-terminus, but this domain fails to rescue a yeast ada2 deletion, indicating functional divergence from its yeast counterpart despite conserved domain architecture (PMID:15246536). The protein is expressed in erythrocytic-stage parasites and its immunodetection pattern is consistent with proteolytic processing (PMID:15246536). Beyond its role as a PfGCN5-associated coactivator, no direct catalytic or gene-target-level function for ADA2 has been characterized in the available corpus.

1. 2004 High

   Establishing that ADA2 physically partners the PfGCN5 acetyltransferase answered whether P. falciparum builds a GCN5/ADA2-type coactivator module, anchoring ADA2 in chromatin-modifying machinery.

   Evidence Yeast two-hybrid and in vitro binding assays plus co-immunoprecipitation reading out associated GCN5-like HAT activity from parasite lysate

   PMID:15075257 PMID:15246536

   Open questions at the time

   • Does not identify the histone residues acetylated by the ADA2-associated activity
   • Does not define which genes the ADA2/PfGCN5 module regulates
   • Does not resolve stoichiometry or full subunit composition of the in vivo complex
2. 2004 Medium

   Characterizing the ADA2 transcript and protein defined its erythrocytic-stage expression and domain layout, and raised the possibility that the protein is proteolytically processed.

   Evidence Northern blot detecting a ~8.5 kb transcript and antiserum Western detection of multiple protein species in mixed blood stages

   PMID:15246536

   Open questions at the time

   • Proteolytic processing is inferred from band pattern, not directly demonstrated
   • Processing sites and functional consequence of any cleavage are unknown
3. 2004 Medium

   Testing cross-species function showed that the ADA2-like domain cannot substitute for yeast ADA2, establishing that the Plasmodium protein has functionally diverged despite conserved architecture.

   Evidence Yeast ada2-deletion complementation assay with the ADA2-like domain

   PMID:15246536

   Open questions at the time

   • Single lab, single negative complementation assay
   • Does not determine which residues or interactions underlie the functional divergence
4. 2019 Medium

   Quantitative interaction proteomics refined the picture by revealing two distinct GCN5/ADA2 complexes and placing ADA2 within this interconnected epigenetic network.

   Evidence Tagging and quantitative interaction proteomics by mass spectrometry in P. falciparum

   PMID:31728527

   Open questions at the time

   • Abstract does not specify whether ADA2 itself was the tagged bait
   • Does not assign ADA2 to a specific one of the two complexes with certainty
   • Functional distinction between the two complexes is not defined

• The direct molecular contribution of ADA2 to complex assembly, acetyltransferase targeting, and specific gene regulation during the parasite life cycle remains unresolved.
• No genetic knockout or knockdown phenotype for ADA2 in the corpus
• No identified target genes or chromatin loci
• No structural model of the ADA2/PfGCN5 interface